Stay updated on SG + Pembrolizumab in HR+ / HER2- MBC Clinical Trial

Sign up to get notified when there's something new on the SG + Pembrolizumab in HR+ / HER2- MBC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the SG + Pembrolizumab in HR+ / HER2- MBC Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.3 to v3.5.0 on the page. The old revision reference is no longer shown.
    Difference
    0.0%
    Check dated 2026-03-19T06:17:56.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    Revision updated to v3.4.3. The previous revision v3.4.2 has been superseded.
    Difference
    0.1%
    Check dated 2026-03-12T02:20:21.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    No substantive content additions or deletions were detected; the study details, eligibility criteria, and outcome measures remain unchanged.
    Difference
    0.0%
    Check dated 2026-03-04T23:58:17.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    Revision indicator updated to v3.4.2 and the government funding status notice (including the prior Revision: v3.4.1) was removed; no study content changes are evident. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T11:39:23.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    Added a notice about a lapse in government funding and that the NIH Clinical Center is open, with status updates linked to opm.gov. Updated the page revision to v3.4.1, replacing v3.4.0.
    Difference
    0.4%
    Check dated 2026-02-04T10:28:02.000Z thumbnail image
  8. Check
    68 days ago
    Change Detected
    Summary
    Added a glossary display option. Updated metadata items include Last Update Submitted that Met QC Criteria, Last Update Posted, No FEAR Act Data, and Revision: v3.4.0, replacing Last Update Submitted that met QC Criteria, Last Update Posted (Estimated), No FEAR Act data, and Revision: v3.3.4.
    Difference
    0.2%
    Check dated 2026-01-28T06:17:42.000Z thumbnail image

Stay in the know with updates to SG + Pembrolizumab in HR+ / HER2- MBC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the SG + Pembrolizumab in HR+ / HER2- MBC Clinical Trial page.